These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 21453726)
1. IL-27 suppresses RANKL expression in CD4+ T cells in part through STAT3. Kamiya S; Okumura M; Chiba Y; Fukawa T; Nakamura C; Nimura N; Mizuguchi J; Wada S; Yoshimoto T Immunol Lett; 2011 Jul; 138(1):47-53. PubMed ID: 21453726 [TBL] [Abstract][Full Text] [Related]
2. IL-27 inhibits the development of regulatory T cells via STAT3. Huber M; Steinwald V; Guralnik A; Brüstle A; Kleemann P; Rosenplänter C; Decker T; Lohoff M Int Immunol; 2008 Feb; 20(2):223-34. PubMed ID: 18156621 [TBL] [Abstract][Full Text] [Related]
3. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state. Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T Int Immunol; 2007 Jun; 19(6):695-702. PubMed ID: 17493959 [TBL] [Abstract][Full Text] [Related]
4. IL-23 induces receptor activator of NF-kappaB ligand expression in fibroblast-like synoviocytes via STAT3 and NF-kappaB signal pathways. Li X; Kim KW; Cho ML; Ju JH; Kang CM; Oh HJ; Min JK; Lee SH; Park SH; Kim HY Immunol Lett; 2010 Jan; 127(2):100-7. PubMed ID: 19900478 [TBL] [Abstract][Full Text] [Related]
5. IFN-beta inhibits human Th17 cell differentiation. Ramgolam VS; Sha Y; Jin J; Zhang X; Markovic-Plese S J Immunol; 2009 Oct; 183(8):5418-27. PubMed ID: 19783688 [TBL] [Abstract][Full Text] [Related]
6. Interleukin-21 maintains the expression of CD16 on monocytes via the production of IL-10 by human naïve CD4+ T cells. Liu Y; Yang B; Ma J; Wang H; Huang F; Zhang J; Chen H; Wu C Cell Immunol; 2011; 267(2):102-8. PubMed ID: 21227406 [TBL] [Abstract][Full Text] [Related]
7. IL-6 activates STAT5 in T cells. Tormo AJ; Letellier MC; Sharma M; Elson G; Crabé S; Gauchat JF Cytokine; 2012 Nov; 60(2):575-82. PubMed ID: 22854263 [TBL] [Abstract][Full Text] [Related]
8. Regulatory effects of IFN-beta on production of osteopontin and IL-17 by CD4+ T Cells in MS. Chen M; Chen G; Nie H; Zhang X; Niu X; Zang YC; Skinner SM; Zhang JZ; Killian JM; Hong J Eur J Immunol; 2009 Sep; 39(9):2525-36. PubMed ID: 19670379 [TBL] [Abstract][Full Text] [Related]
9. Oral administration of type-II collagen suppresses IL-17-associated RANKL expression of CD4+ T cells in collagen-induced arthritis. Ju JH; Cho ML; Jhun JY; Park MJ; Oh HJ; Min SY; Cho YG; Hwang SY; Kwok SK; Seo SH; Yoon CH; Park SH; Kim HY Immunol Lett; 2008 Apr; 117(1):16-25. PubMed ID: 18242716 [TBL] [Abstract][Full Text] [Related]
10. The antirheumatic drug leflunomide inhibits osteoclastogenesis by interfering with receptor activator of NF-kappa B ligand-stimulated induction of nuclear factor of activated T cells c1. Urushibara M; Takayanagi H; Koga T; Kim S; Isobe M; Morishita Y; Nakagawa T; Löeffler M; Kodama T; Kurosawa H; Taniguchi T Arthritis Rheum; 2004 Mar; 50(3):794-804. PubMed ID: 15022321 [TBL] [Abstract][Full Text] [Related]
11. Recently activated naive CD4 T cells can help resting B cells, and can produce sufficient autocrine IL-4 to drive differentiation to secretion of T helper 2-type cytokines. Croft M; Swain SL J Immunol; 1995 May; 154(9):4269-82. PubMed ID: 7536767 [TBL] [Abstract][Full Text] [Related]
12. A positive feedback loop of IL-21 signaling provoked by homeostatic CD4+CD25- T cell expansion is essential for the development of arthritis in autoimmune K/BxN mice. Jang E; Cho SH; Park H; Paik DJ; Kim JM; Youn J J Immunol; 2009 Apr; 182(8):4649-56. PubMed ID: 19342640 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-10 inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos and c-Jun in RAW264.7 cells and mouse bone marrow cells. Mohamed SG; Sugiyama E; Shinoda K; Taki H; Hounoki H; Abdel-Aziz HO; Maruyama M; Kobayashi M; Ogawa H; Miyahara T Bone; 2007 Oct; 41(4):592-602. PubMed ID: 17627913 [TBL] [Abstract][Full Text] [Related]
14. Epigallocatechin-3-gallate inhibits osteoclastogenesis by down-regulating c-Fos expression and suppressing the nuclear factor-kappaB signal. Lee JH; Jin H; Shim HE; Kim HN; Ha H; Lee ZH Mol Pharmacol; 2010 Jan; 77(1):17-25. PubMed ID: 19828731 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-4 inhibits RANKL-induced expression of NFATc1 and c-Fos: a possible mechanism for downregulation of osteoclastogenesis. Kamel Mohamed SG; Sugiyama E; Shinoda K; Hounoki H; Taki H; Maruyama M; Miyahara T; Kobayashi M Biochem Biophys Res Commun; 2005 Apr; 329(3):839-45. PubMed ID: 15752732 [TBL] [Abstract][Full Text] [Related]
16. IL-1 plays an important role in the bone metabolism under physiological conditions. Lee YM; Fujikado N; Manaka H; Yasuda H; Iwakura Y Int Immunol; 2010 Oct; 22(10):805-16. PubMed ID: 20679512 [TBL] [Abstract][Full Text] [Related]
17. Protein expression and functional difference of membrane-bound and soluble receptor activator of NF-kappaB ligand: modulation of the expression by osteotropic factors and cytokines. Nakashima T; Kobayashi Y; Yamasaki S; Kawakami A; Eguchi K; Sasaki H; Sakai H Biochem Biophys Res Commun; 2000 Sep; 275(3):768-75. PubMed ID: 10973797 [TBL] [Abstract][Full Text] [Related]
18. NF-kappaB inhibitor dehydroxymethylepoxyquinomicin suppresses osteoclastogenesis and expression of NFATc1 in mouse arthritis without affecting expression of RANKL, osteoprotegerin or macrophage colony-stimulating factor. Kubota T; Hoshino M; Aoki K; Ohya K; Komano Y; Nanki T; Miyasaka N; Umezawa K Arthritis Res Ther; 2007; 9(5):R97. PubMed ID: 17892600 [TBL] [Abstract][Full Text] [Related]
19. Activated human T cells directly induce osteoclastogenesis from human monocytes: possible role of T cells in bone destruction in rheumatoid arthritis patients. Kotake S; Udagawa N; Hakoda M; Mogi M; Yano K; Tsuda E; Takahashi K; Furuya T; Ishiyama S; Kim KJ; Saito S; Nishikawa T; Takahashi N; Togari A; Tomatsu T; Suda T; Kamatani N Arthritis Rheum; 2001 May; 44(5):1003-12. PubMed ID: 11352231 [TBL] [Abstract][Full Text] [Related]
20. T-bet is a STAT1-induced regulator of IL-12R expression in naïve CD4+ T cells. Afkarian M; Sedy JR; Yang J; Jacobson NG; Cereb N; Yang SY; Murphy TL; Murphy KM Nat Immunol; 2002 Jun; 3(6):549-57. PubMed ID: 12006974 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]